文献速递运动医学创伤骨科

激素避孕对前交叉韧带损伤的保护效应是否被高估:口服避孕药与ACL损伤的系统综述与Meta分析

Has the Protective Effect of Hormonal Contraception Been Overestimated? A Systematic Review and Meta-analysis of Oral Contraceptive Pills and ACL Injury.
PubMed 文献 · Am J Sports Med · 2026-04-09

该系统综述与Meta分析纳入8项研究共18,103,890名参与者,评估激素避孕(主要为口服避孕药)与女性ACL损伤风险的关联。汇总风险比为0.88(95%CI,0.77-1.01),异质性高(I2=97.3%),Egger回归未发现显著发表偏倚(P=.426)。结论认为激素避孕尤其口服避孕药似乎不降低女性ACL损伤风险。

要点

  • 激素避孕(主要为口服避孕药)与ACL损伤风险的汇总RR为0.88(95%CI,0.77-1.01)。
  • 异质性高(I2=97.3%),Egger回归未发现显著发表偏倚(P=.426)。
  • 鉴于潜在副作用与缺乏确切获益,不应仅为预防损伤而推荐激素避孕。

核心结论

  • 激素避孕使用尤其口服避孕药似乎不降低女性ACL损伤风险。
  • 鉴于激素避孕的潜在副作用与缺乏确切获益,临床不应仅为损伤预防而推荐其使用。

研究设计与样本

  • 系统综述与Meta分析,证据等级3级,遵循PRISMA指南检索PubMed、OVID(MEDLINE)和Embase数据库至2025年3月。
  • 纳入报告激素避孕使用者与非使用者ACL损伤发生率的研究,共8项研究、18,103,890名参与者。
  • 所有研究均评估口服避孕药,其中3项还纳入其他激素避孕形式。
  • 采用随机效应Meta分析计算汇总风险比,并通过漏斗图和Egger回归评估发表偏倚。

主要发现

  • 激素避孕使用者相比非使用者的ACL损伤汇总风险比为0.88(95%CI,0.77-1.01)。
  • 异质性高(I2=97.3%)。
  • Egger回归未显示显著发表偏倚(P=.426)。

关键数值与推荐

  • 汇总风险比0.88(95%CI,0.77-1.01),对象为激素避孕使用者对比非使用者,结局为ACL损伤。
  • 异质性I2=97.3%,发表偏倚检验P=.426。

临床怎么用

  • 临床不应仅为预防ACL损伤而推荐激素避孕使用。
  • 未来研究应关注非口服避孕药的ACL损伤预防策略、多样化运动人群及激素避孕配方的标准化报告。

局限性

  • 异质性高(I2=97.3%)。
  • 所有研究均评估口服避孕药,仅3项纳入其他激素避孕形式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hormonal contraception (HC), including oral contraceptive pills (OCPs) and long-acting reversible contraceptives, is widely used by reproductive-aged women for various medical indications. Emerging evidence suggests a possible association between HC use and reduced anterior cruciate ligament (ACL) injury risk; however, no meta-analysis has systematically evaluated this relationship. PURPOSE: To determine whether HC use reduces the risk of ACL injury in females through a systematic review and meta-analysis. STUDY DESIGN: Meta-analysis; Level of evidence, 3. METHODS: A systematic search of the PubMed, OVID (MEDLINE), and Embase databases was conducted from inception through March 2025 following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Studies were included if they reported ACL injury incidence among both HC users and nonusers. Data were synthesized using a random-effects meta-analysis to calculate a pooled risk ratio. Publication bias was evaluated using funnel plots and Egger regression. RESULTS: Eight studies consisting of 18,103,890 participants met inclusion criteria. All studies evaluated OCPs, and 3 included other forms of HC. The pooled risk ratio for ACL injury among HC users versus nonusers was 0.88 (95% CI, 0.77-1.01). Heterogeneity was high (I2 = 97.3%), and Egger regression showed no significant publication bias (P = .426). CONCLUSION: Hormonal contraceptive use, particularly OCPs, does not appear to reduce ACL injury risk in females. Given the potential side effects of HC and the lack of conclusive benefit, clinicians should not recommend HC use solely for injury prevention. Future research should focus on non-OCP preventive strategies for ACL injury, diverse athletic populations, and standardized reporting of HC formulations.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Paska J, Watson SL, Larrabee GA, et al. Has the Protective Effect of Hormonal Contraception Been Overestimated? A Systematic Review and Meta-analysis of Oral Contraceptive Pills and ACL Injury. Am J Sports Med. 2026. PMID: 41952609. doi:10.1177/03635465261434017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。